Market revenue in 2023 | USD 186.4 million |
Market revenue in 2030 | USD 348.1 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Topical hemostat |
Fastest growing segment | Topical hemostat |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical hemostat, Adhesive & tissue sealant |
Key market players worldwide | Johnson & Johnson, Cryolife, Cohera Medical, Pfizer Inc, Becton Dickinson & Co, Baxter International Inc, HyperBranch Medical Technology, Zimmer Biomet Holdings Inc, B. Braun Medical, Smith & Nephew PLC, Advanced Medical Solutions, Integra Lifesciences Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostasis & tissue sealing agents market will help companies and investors design strategic landscapes.
Topical hemostat was the largest segment with a revenue share of 76.66% in 2023. Horizon Databook has segmented the South Korea hemostasis & tissue sealing agents market based on topical hemostat, adhesive & tissue sealant covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hemostasis & tissue sealing agents market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hemostasis & tissue sealing agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account